PDCD4 and carcinoma: Then, experiments from both the PDCD4 transgene and knockout mice indicated that PDCD4 could inhibit cutaneous tumor incidence and papilloma-to-carcinoma conversion-frequency induced by TPA (12-O-tetradecanoylphorbol-13-acetate) [3,4].